| Title |
Unanticipated toxicities from anticancer therapies: Survivors’ perspectives
|
|---|---|
| Published in |
Supportive Care in Cancer, December 2009
|
| DOI | 10.1007/s00520-009-0769-1 |
| Pubmed ID | |
| Authors |
Mona Gandhi, Karen Oishi, Beth Zubal, Mario E. Lacouture |
| Abstract |
Improved therapies in oncology have resulted in increased survival across numerous malignancies, shifting attention to other aspects of the cancer experience. In particular, the impact of treatment-related toxicities has gained considerable attention, due to their physical and psychosocial effects, and possible impact on clinical outcome. These untoward events have not been examined from the survivors' perspective. |
Mendeley readers
The data shown below were compiled from readership statistics for 50 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 50 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 7 | 14% |
| Other | 5 | 10% |
| Student > Doctoral Student | 5 | 10% |
| Student > Ph. D. Student | 5 | 10% |
| Student > Bachelor | 4 | 8% |
| Other | 11 | 22% |
| Unknown | 13 | 26% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 13 | 26% |
| Nursing and Health Professions | 9 | 18% |
| Agricultural and Biological Sciences | 3 | 6% |
| Psychology | 3 | 6% |
| Social Sciences | 2 | 4% |
| Other | 4 | 8% |
| Unknown | 16 | 32% |